Physician profile
Victor V Bugay
NPI 1568416352
$1,747.52
in general payments reported to CMS, 2019-2025
39 companies · $755 in 2025
The $755 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $408 · 2020: $227 · 2021: $164 · 2022: $40.54 · 2023: $47.32 · 2024: $106 · 2025: $755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $907.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $162.46 | 2019-2025 | Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $157.73 | 2024-2025 | |
| Glaxosmithkline, LLC. | $119.92 | 2019-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Amarin Pharma, INC. | $112.21 | 2019-2021 | |
| Lilly USA, LLC | $90.69 | 2019-2025 | Mounjaro, Zepbound |
| Amgen INC. | $77.01 | 2025 | Repatha, Otezla |
| Medtronic, INC. | $72.98 | 2024-2025 | Inceptiv, Closurefast, Micra |
| Astrazeneca Pharmaceuticals LP | $69.62 | 2019-2025 | Farxiga, Breztri |
| Janssen Pharmaceuticals, INC | $68.15 | 2019-2021 | |
| Boston Scientific Corporation | $68.10 | 2025 | Lux-Dx Insertable Cardiac Monitor, Bodyguardian |
| Insightec,INC | $55.31 | 2025 | Exablate |
| Novartis Pharmaceuticals Corporation | $54.27 | 2019-2025 | |
| Atricure, INC. | $42.85 | 2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Eisai INC. | $41.05 | 2020-2021 | |
| Altathera Pharmaceuticals LLC | $38.60 | 2025 | Sotalol Hydrochloride |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $37.22 | 2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $36.48 | 2019 | |
| Phathom Pharmaceuticals, INC. | $36.07 | 2025 | Voquezna |
| Abbvie INC. | $35.68 | 2024-2025 | |
| Philips North America LLC | $33.23 | 2022-2023 | |
| Nestle Healthcare Nutrition INC. | $27.71 | 2020-2021 | |
| Sanofi Pasteur INC. | $26.35 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $24.57 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.19 | 2019 | |
| Dexcom, INC. | $23.24 | 2025 | Dexcom G6 Transmitter |
| Medtronic Vascular, INC. | $21.98 | 2019 | |
| Abiomed | $20.62 | 2025 | |
| Kyowa Kirin, INC. | $18.18 | 2025 | |
| Impulse Dynamics (USA) INC. | $18.04 | 2025 | Optimizer |
| Avanir Pharmaceuticals, INC. | $14.75 | 2020 | |
| Xeris Pharmaceuticals, INC. | $14.49 | 2022 | |
| Biogen, INC. | $14.15 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $13.70 | 2020 | |
| Daiichi Sankyo INC. | $13.53 | 2020 | |
| Seqirus USA INC | $13.36 | 2020 | |
| Pfizer INC. | $13.25 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.17 | 2020 | |
| Cequr Corporation | $11.56 | 2022 | |
| Allergan, INC. | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Bugay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.